In this article, we will discuss Niraparib (Dosage Overview). So, let’s get started.
Niraparib is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
The recommended dose of Niraparib as monotherapy is 300 mg (three 100 mg capsules) taken orally once daily.
Instruct patients to take their dose of Niraparib at approximately the same time each day. Each capsule should be swallowed whole. Niraparib may be taken with or without food. Bedtime administration may be a potential method for managing nausea. Patients should start treatment with Niraparib no later than 8 weeks after their most recent platinum-containing regimen.
Niraparib treatment should be continued until disease progression or unacceptable toxicity.